ROR1-TriKE(GT Biopharma)

N/A

Report date: 2022/09/06 18:03:22

Base Information

Drug NameROR1-TriKE(GT Biopharma)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cells stimulantsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects
TargetsNot applicable
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGt Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesGt Biopharma Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A